Grailbio
Menlo Park, US · 1 known investors
GRAIL develops a blood-based multi-cancer early detection test called Galleri that uses next-generation sequencing and machine learning to screen for multiple cancer types before symptoms appear. The company serves healthcare providers, insurers, and patients seeking early cancer detection.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
U
UNKNOWN